-
Pfizer's Toviaz safe, effective in treating overactive bladder in elderly patients
NEW YORK — A drug made by Pfizer appears to work in treating symptoms of overactive bladder in elderly patients, according to results of a clinical trial released Monday.
Pfizer said that results of study A0221049 of the drug Toviaz (fesoterodine fumarate) worked better than placebo in reducing the number of urgency urinary incontinence episodes. The 12-week study enrolled 562 elderly people in the United States. The drug already has Food and Drug Administration approval for treating overactive bladder.
-
Study tracks development, integration of MTM
WASHINGTON — The concept of medication therapy management has become more developed, and certain aspects of it have become established within the organizations providing and paying for it, according to a white paper published in the Journal of the American Pharmacists Association.